Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

(2013) B. Venugopal et al.   CLINICAL CANCER RESEARCH

Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems

(2011) S. S. More et al.   CLINICAL CANCER RESEARCH

Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585

(2010) Thorsten Stühmer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells

(2010) Jyoti Panicker et al.   CELL CYCLE

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

(2010) Maryam Fouladi et al.   JOURNAL OF CLINICAL ONCOLOGY

National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing

(2010) Min H. Kang et al.   PEDIATRIC BLOOD & CANCER

Rational Combinations Using HDAC Inhibitors

(2009) M. Bots et al.   CLINICAL CANCER RESEARCH

JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

(2009) J. Arts et al.   CLINICAL CANCER RESEARCH

HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling

(2009) Vikram D. Kekatpure et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor

(2009) Wei-Gang Tong et al.   LEUKEMIA RESEARCH

Initial testing of aplidin by the pediatric pre-clinical testing program

(2009) Christopher L. Morton et al.   PEDIATRIC BLOOD & CANCER

Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program

(2009) Nino Keshelava et al.   PEDIATRIC BLOOD & CANCER

HDAC expression and clinical prognosis in human malignancies

(2008) Wilko Weichert   CANCER LETTERS

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

(2008) Stephanie Spange et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program

(2008) Malcolm A. Smith et al.   PEDIATRIC BLOOD & CANCER

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

(2007) Peter J. Houghton et al.   PEDIATRIC BLOOD & CANCER